JOURNAL OF RHEUMATOLOGY, cilt.34, sa.3, ss.501-509, 2007 (SCI-Expanded)
Objective. To obtain a consensus on the minimal clinically relevant treatment effect in various scleroderma disease outcome measures to be used in future clinical trials.